Trevi Therapeutics, Inc. TRVI Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$45.61M+3.7% | -$42.76M+10.8% | -$45.86M-3.5% | -$47.3M-22.0% | -$47.35M-41.1% | ||
| $141K-5.4% | $144K-2.0% | $151K+4.9% | $149K+4.2% | $149K+7.2% | ||
| $6.17M+51.4% | $5.19M+44.5% | $4.75M+48.2% | $4.33M+48.6% | $4.07M+75.8% | ||
| -$45.3M-9.8% | -$42.09M-10.0% | -$44.01M-25.5% | -$42.68M-30.2% | -$41.27M-21.4% | ||
| —— | —— | —— | —— | —— | ||
| -$67.19M— | -$94.11M— | -$87.37M— | -$28.77M— | —— | ||
| $112.53M+60.3% | $121.01M+96.8% | $172.2M+1,628% | $175.55M— | $70.22M— | ||
| $38K-99.3% | -$15.18M-993% | $40.82M+512% | $104.1M+13,293% | $5.56M+158% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Trevi Therapeutics, Inc. generate?
- Trevi Therapeutics, Inc. (TRVI) generated -$45.3M in operating cash flow over the trailing twelve months.
- What is Trevi Therapeutics, Inc.'s free cash flow?
- After $143.0K of capital expenditures, Trevi Therapeutics, Inc.'s free cash flow was -$44.9M over the trailing twelve months, down 35.4% year over year.
- Where does Trevi Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Trevi Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.